Novel human antibody stalls spread of aggressive prostate cancer in preclinical study
TL;DR Summary
Researchers at Umeå University and collaborators developed a fully human antibody that stopped growth and metastatic spread of an aggressive prostate cancer in preclinical tests, via a newly identified mechanism that may carry a lower risk of side effects. While promising, the therapy requires further safety studies and regulatory approval before clinical use, and researchers plan to explore its potential against other solid tumors.
Topics:health#cancer-therapy#health-and-medicine#metastasis#monoclonal-antibody#preclinical#prostate-cancer
- New antibody drug stops aggressive prostate cancer from spreading ScienceDaily
- Jarad Martin: NINJA Prostate Cancer Trial Completes Recruitment With 472 Participants Oncodaily
- Researchers Develop a Fully Human Antibody That Halted Aggressive Prostate Cancer Growth and Spread in Lab Models Medical Daily
- A new generation of prostate cancer drugs is raising hope—here’s why Futura, le média qui explore le monde
- Researchers Uncover a Promising New Way To Stop Prostate Cancer From Spreading SciTechDaily
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
5 min
vs 6 min read
Condensed
94%
1,128 → 64 words
Want the full story? Read the original article
Read on ScienceDaily